Key facts
- Avita Pharmacy’s last known valuation is $390.0M (Nov 2019).
- It has raised $1.5B; the latest was PE Growth/Expansion in Oct 2025.
- Notable investors include Kinderhook Industries.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Avita Pharmacy
- ·The full record, as it builds
Funding rounds
No funding rounds for Avita Pharmacy are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Avita Pharmacy
Provider of individualized pharmacy care services intended to support patient health and optimize partner performance. The company's platform offers onsite pharmacies, delivery options, refill support, and culturally competent care, enabling healthcare organizations and underserved communities to improve access, compliance, and health outcomes.
- Sector
- Healthcare
- HQ
- Baton Rouge, LA, United States
- Founded
- 1938
- Employees
- 21,900
- Website
- avitapharmacy.com/
- Ownership
- Privately Held (backing)
Avita Pharmacy doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Avita Pharmacy shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Avita Pharmacy in its N-PORT filings yet. We sweep new filings monthly.